Molecular Markers for Colorectal Cancer
- PMID: 28501255
- DOI: 10.1016/j.suc.2017.01.014
Molecular Markers for Colorectal Cancer
Abstract
Colorectal cancers develop through at least 3 major pathways, including chromosomal instability, mismatch repair, and methylator phenotype. These pathways can coexist in a single individual and occur in both sporadic and inherited colorectal cancers. In spite of the unique molecular and genetic signatures of colorectal cancers, nonspecific chemotherapy based on the antineoplastic effects of 5-fluorouracil is the cornerstone of therapy for stage III and some stage II disease. Techniques to recognize colorectal cancer at the molecular level have facilitated development of new signature drugs designed to inhibit the unique pathways of colorectal cancer growth and immunity.
Keywords: Antibodies; Antineoplastic combined chemotherapy; Biomarkers; Colorectal neoplasm; Drug therapy; Monoclonal/therapeutic use; Tumor/genetics.
Copyright © 2017 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical